Evidence map›Paper›PMID 33178868›Full record

ArticleReports of biochemistry & molecular biology2020

Examining the Frequency of the

Mojila Nasseri, Fatemeh Keyfi, Raheleh Rahbarian, Majid Rajabian, Mohammad Reza Abbaszadegan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Reports of biochemistry & molecular biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Mojila NasseriDepartment of Biochemistry, Payamenoor University, Tehran, Iran.
Fatemeh KeyfiDepartment of Medical Laboratory Sciences, Varastegan Institute for Medical Sciences, Mashhad, Iran.
Raheleh RahbarianDepartment of Biochemistry, Payamenoor University, Tehran, Iran.
Majid RajabianDepartment of biology, Payamenoor University, Tehran, Iran.
Mohammad Reza AbbaszadeganPardis Clinical and Genetics Laboratory, Mashhad, Iran.
Payame Noor University · IRVarastegan Institute for Medical Sciences

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundJanus kinase 2 (

methodsA total of 213 patients with myeloproliferative diseases (MPDs), were included in the study. Real-time PCR was used to detect the presence of the

resultsOf the 213 patients with MPDs, approximately 60 (28%) patients were positive for the

conclusionOf the examined cohort in North Eastern Iran, 28% of the patients with MPNs were found to have the

Indexed as

AK2 (V617F)JAK-STAT pathwayMPD Real-Time PCRTreatment

Identifiers

PMID33178868
PMCPMC7603260
OpenAlexW3097321916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.